Biohaven Ltd (NYSE:BHVN) price on Thursday, May 01, rose 1.49% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $22.45.
A look at the stock’s price movement, the close in the last trading session was $22.12, moving within a range at $21.41 and $22.89. The beta value (5-Year monthly) was 4.152. Turning to its 52-week performance, $55.70 and $15.79 were the 52-week high and 52-week low respectively. Overall, BHVN moved -0.66% over the past month.
Biohaven Ltd’s market cap currently stands at around $2.29 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BHVN is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend BHVN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BHVN’s current price about 12.90% and -14.69% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.44, while 7-day volatility ratio is 13.25% and 11.04% in the 30-day chart. Further, Biohaven Ltd (BHVN) has a beta value of 4.18, and an average true range (ATR) of 2.15. Analysts have given the company’s stock an average 52-week price target of $60, forecast between a low of $57 and high of $61. Looking at the price targets, the low is -153.9% off current price level while to achieve the yearly target high, price needs to move -171.71%. Nonetheless, investors will most likely welcome a -167.26% jump to $60 which is the analysts’ median price.
If we refocus on Biohaven Ltd (NYSE:BHVN), historical trading data shows that trading volumes averaged 2.65 over the past 10 days and 1.44 million over the past 3 months. The company’s latest data on shares outstanding shows there are 101.22 million shares.
The 12.68% of Biohaven Ltd’s shares are in the hands of company insiders while institutional holders own 90.62% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.69 million on 2025-04-15, giving us a short ratio of 5.15. The data shows that as of 2025-04-15 short interest in Biohaven Ltd (BHVN) stood at 851.0 of shares outstanding, with shares short rising to 7.33 million registered in 2025-03-14. Current price change has pushed the stock -39.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BHVN stock continues to rise going into the next quarter.
